Investor Information

OctoNerv is developing the Electronic Breast Nipple Implant (EBNI), the first dynamic, electronically controlled nipple implant designed to support breast reconstruction after mastectomy. Our mission is to solve a long-standing clinical problem: the lack of durable, realistic nipple projection.

Why Invest in OctoNerv?

EBNI addresses a critical unmet need in reconstructive medicine. Millions of women undergo mastectomy and reconstruction each year, yet current nipple reconstruction options often flatten over time and lack functional behavior. Hospitals, surgeons, and patients have expressed strong interest in a solution that offers long-term projection and enhanced realism.

Prototype Status

OctoNerv has completed its first functional electronic prototype. The current version demonstrates controlled projection, BLE communication, and wireless charging. This is not the final product. Additional iterations will require advanced materials, miniaturized components, and expanded engineering development as funding becomes available.

Market Opportunity

Over 2.3 million breast cancer surgeries occur worldwide each year. With increasing interest in reconstruction, the demand for better nipple solutions continues to grow. EBNI offers a differentiated product with potential adoption across major surgical centers.

Use of Funding

Investment capital will support:

Partnership Opportunities

OctoNerv is open to strategic partnerships with:

Contact for Investors

Interested investors may request detailed materials, including the investor deck, financial projections, development milestones, and partnership terms.

OctoNerv LLC
1600 Lehigh Parkway E, 3B
Allentown, PA 18103
United States

Email: steven@octonervs.com
Website: octonervs.com